Home › Icagen Issued U.S. Patent Covering Diagnostic And Discovery Applications Of Its Proprietary XRpro X-Ray Fluorescence Technology
 

Keywords :   


Icagen Issued U.S. Patent Covering Diagnostic And Discovery Applications Of Its Proprietary XRpro X-Ray Fluorescence Technology

2016-06-01 06:00:52| drugdiscoveryonline Home Page

Icagen, Inc. recently announced that the U.S. Patent and Trademark Office has granted the company patent number 9,335,284 B2, “Methods for Analysis Using X-Ray Fluorescence,” covering applications of the company’s proprietary XRpro X-ray fluorescence technology to the development of biomarkers and diagnostics

Tags: technology applications issued patent

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »